Orthobiologics company developing MagnetOs bone graft technology for spine and orthopedics
Kuros Biosciences develops bone graft biologics for spine, orthopedic, neurosurgery and foot & ankle procedures, with US operations run from Alpharetta, Georgia. Its stack pairs Veeva and HubSpot on the commercial side with a heavy integration and automation layer (Boomi, Workato, SnapLogic, UiPath, Power Automate) spanning SAP, NetSuite and Dynamics 365. Accelerating US hiring tilts toward regulatory, clinical and HR build-out, including a new Total Rewards Director.
Notable leadership hires: Total Rewards Director
Kuros Biosciences is a publicly listed biotech company focused on orthobiologics, with its flagship MagnetOs bone graft aimed at improving bone healing. Its products serve surgeons in spine surgery, orthopedics, neurosurgery and foot & ankle care. The company is Swiss-headquartered and traded on the SIX Swiss Exchange, with operations in the Netherlands and the United States, where it is based in Alpharetta, Georgia. It employs 51–200 people and reports a commercial and research presence across more than 20 markets, backed by a sizable orthobiologics patent portfolio and clinical trial program.
Kuros runs ERP and finance on SAP, NetSuite, Oracle and Dynamics 365, uses Veeva, HubSpot and Highspot commercially, Power BI and Tableau for analytics, and Boomi, Workato and UiPath for integration and automation.
Yes. Hiring is accelerating in the United States across healthcare, HR, operations, regulatory, engineering, logistics, marketing and sales, with senior and leadership roles such as a Total Rewards Director.
Current initiatives include post-market clinical follow-up, real-world evidence generation, global registration strategy, regulatory filings for new products, and a compensation program and HR technology overhaul.
Other companies in the same industry, closest in size
Kuros Biosciences's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.